SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-045120
Filing Date
2024-04-17
Accepted
2024-04-17 16:15:09
Documents
1
Period of Report
2024-04-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7847
  Complete submission text file 0000950170-24-045120.txt   9972
Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Issuer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605
Business Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605 44 7557 251 563
Apeiron Investment Group Ltd. (Reporting) CIK: 0001845711 (see all company filings)

State of Incorp.: O1 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40493 | Film No.: 24851238

Mailing Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605
Business Address
Angermayer Christian (Reporting) CIK: 0001845872 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40493 | Film No.: 24851237